95977-29-0

Usage

Uses

Used in Agriculture:
Haloxyfop-P is used as a herbicide for controlling a wide range of broadleaf and grassy weeds in various crops, including cassia fields. Its application helps to protect the crops from competition and damage caused by these weeds, ensuring healthy growth and higher yields.
Used in Cassia Fields:
Specifically in cassia fields, Haloxyfop-P is used as a selective herbicide to control weeds that may compete with cassia plants for nutrients, water, and sunlight. By eliminating these weeds, the herbicide promotes the growth and development of cassia plants, leading to a more productive and profitable harvest.
As a Pesticide Residue in Vegetables:
While Haloxyfop-P is primarily used in non-crop areas or in crops like cassia, it is also important to monitor its residues in vegetables to ensure food safety. This involves setting maximum residue limits (MRLs) and conducting regular testing to prevent any potential health risks associated with the consumption of contaminated produce.

InChI:InChI=1/C15H11ClF3NO4/c1-8(14(21)22)23-10-2-4-11(5-3-10)24-13-12(16)6-9(7-20-13)15(17,18)19/h2-8H,1H3,(H,21,22)/t8-/m1/s1

Upstream product

• 72619-32-0 (R)-2-[4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]phenoxy]propanoic acid methyl ester 
• 69045-84-7 2,3-dichloro-5-trifluoromethylpyridine 
• 94050-90-5 (R)-2-(4-hydroxyphenoxy)propionic acid 
• 69806-34-4 haloxyfop 
• 69045-89-2 2-(4'-hydroxyphenoxy)-3-chloro-5-trifluoromethylpyridine 
• 94050-90-5 (RS)-2-(4-hydroxyphenoxy)propionic acid 
• 29617-66-1 (S)-2-chloropropanoic acid 
• 73246-45-4 methyl-(S)-2-chloropropionate 

Relevant academic research and scientific papers

Structure, activity, and inhibition of the carboxyltransferase β-Subunit of acetyl coenzyme a carboxylase (AccD6) from mycobacterium tuberculosis

In Mycobacterium tuberculosis, the carboxylation of acetyl coenzyme A (acetyl-CoA) to produce malonyl-CoA, a building block in long-chain fatty acid biosynthesis, is catalyzed by two enzymes working sequentially: a biotin carboxylase (AccA) and a carboxyl

Evaluation of the Edman degradation product of vancomycin bonded to core-shell particles as a new HPLC chiral stationary phase

A modified macrocyclic glycopeptide-based chiral stationary phase (CSP), prepared via Edman degradation of vancomycin, was evaluated as a chiral selector for the first time. Its applicability was compared with other macrocyclic glycopeptide-based CSPs: TeicoShell and VancoShell. In addition, another modified macrocyclic glycopeptide-based CSP, NicoShell, was further examined. Initial evaluation was focused on the complementary behavior with these glycopeptides. A screening procedure was used based on previous work for the enantiomeric separation of 50 chiral compounds including amino acids, pesticides, stimulants, and a variety of pharmaceuticals. Fast and efficient chiral separations resulted by using superficially porous (core-shell) particle supports. Overall, the vancomycin Edman degradation product (EDP) resembled TeicoShell with high enantioselectivity for acidic compounds in the polar ionic mode. The simultaneous enantiomeric separation of 5 racemic profens using liquid chromatography-mass spectrometry with EDP was performed in approximately 3?minutes. Other highlights include simultaneous liquid chromatography separations of rac-amphetamine and rac-methamphetamine with VancoShell, rac-pseudoephedrine and rac-ephedrine with NicoShell, and rac-dichlorprop and rac-haloxyfop with TeicoShell.

Synthesis and herbicidal activity of 2-(4-aryloxyphenoxy)propionamides

Two novel 2-(4-aryloxyphenoxy)propionamide derivatives were synthesized based on the structure of metamifop. Their structures were confirmed by 1H nuclear magnetic resonance, elemental analysis, and optical rotation. The preliminary bioassay re

Aryloxy-phenoxy alkane acid derivative and medicinal application thereof

The invention discloses an aryloxy-phenoxy alkane acid derivative and a medicinal application thereof. The aryloxy-phenoxy alkane acid derivative is shown as the chemical formula I in the specification, wherein R1 is any one of hydrogen, alkyl containing

Tetrahydro naphthalene-2-aryloxy phenoxy alkyl ketone compound with anti-tumor activity and pharmaceutical application of compound

The invention discloses a tetrahydro naphthalene-2-aryloxy phenoxy alkyl ketone compound and a medical application thereof. The chemical structural formula of the compound is as shown in the formula Iin the specification, wherein R1, R2, R3 and R4 are any

Tetrahydroisoquinoline-2-aryloxyphenoxyalkyl ketone compound and application thereof

The invention discloses a tetrahydroisoquinoline-2-aryloxyphenoxyalkyl ketone compound and application thereof. The chemical structural formula of the compound is shown in formula I or II shown in the description, where each of R, R, R and R i

2-(hexahydric aryloxy phenoxy)alkanoic acid derivative and application thereof

The invention discloses a 2-(hexahydric aryloxy phenoxy)alkanoic acid derivative and application thereof as a herbicide. The chemical formula of the 2-(hexahydric aryloxy phenoxy)alkanoic acid derivative is shown in the specification, wherein R, R,

Pyridyl-3-yl-aryloxyphenoxynoic acid ester compounds and application thereof

The invention discloses pyridyl-3-yl-aryloxyphenoxynoic acid ester compounds and herbicidal activities thereof. The chemical structural formula is disclosed as Formula I or II, wherein X is nitrogen or carbon; Y is -N=CH- or oxygen; X1, X2 and X3 are resp

2-(4-aryloxy phenoxy)montanic acid naphthalene ester compound and application thereof

The invention discloses a 2-(4-aryloxy phenoxy)montanic acid naphthalene ester compound and application thereof as a herbicide. The chemical structural formula of the 2-(4-aryloxy phenoxy)montanic acid naphthalene ester compound is shown as the formula I

Aryloxyphenoxy alkane acid derivative with biological activity and preparation method thereof

The invention discloses an aryloxyphenoxy alkane acid derivative and herbicidal activity thereof. The chemical structural formula of the derivative is shown as a formula I or II, and the structural formula is as shown in the specification, wherein R1 is a